What is NDC 64980-721?

64980-721 is the product NDC for AQUASOL A Parenteral (water-miscible retinyl palmitate), Vitamin a palmitate 15 mg/mL injection, solution, listed with the FDA by Rising Pharma Holdings, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

AQUASOL A Parenteral (Water-Miscible Retinyl Palmitate).

Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for AQUASOL A Parenteral?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

AQUASOL A Parenteral NDC 64980-721 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)64980-721Labeler and product segments. Claims need a package NDC.

Product NDC at billing width64980-0721Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
64980-721-02	64980072102	1 VIAL, SINGLE-DOSE in 1 CARTON (64980-721-02) / 2 mL in 1 VIAL, SINGLE-DOSEMarketed from Feb 27, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): AQUASOL A Parenteral
Generic name (nonproprietary): water-miscible retinyl palmitate
Active ingredients: Vitamin a palmitate — 15 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular
Labeler: Rising Pharma Holdings, Inc.NDC labeler code 64980
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 006823
Marketing start: Feb 27, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 64980-721_0c90883f-68ce-459d-8239-4e96e0b49c80SPL ID 0c90883f-68ce-459d-8239-4e96e0b49c80SPL set ID 1abd66eb-6ac8-4a9e-a609-251e46ea1a27RxCUI 210972, 313650UNII 1D1K0N0VVC

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N464980072102 followed by a unit qualifier and the quantity

Package 64980-0721-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 3, 2026.

Indications (excerpt from the label)

INDICATIONS Retinyl palmitate injection is effective for the treatment of vitamin A deficiency. The parenteral administration is indicated when the oral administration is not feasible as in anorexia, nausea, vomiting, pre- and postoperative conditions, or it is not available as in the “Malabsorption Syndrome” with accompanying steatorrhea. Pediatric Use: Vitamin A treatment for deficiency states has been recognized as an especially effective and important therapy in the pediatric population. Vitamin A supplementation for deficiency states in this population has been addressed by the Committee on Clinical Practice Issues of the American Society for Clinical Nutrition, by the American Society …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 64980-721

What is NDC 64980-721?: 64980-721 is the product NDC for AQUASOL A Parenteral (water-miscible retinyl palmitate), Vitamin a palmitate 15 mg/mL injection, solution, listed with the FDA by Rising Pharma Holdings, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: AQUASOL A Parenteral (Water-Miscible Retinyl Palmitate).
What is the active ingredient?: Vitamin a palmitate.
Who is the labeler?: Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for AQUASOL A Parenteral?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

AQUASOL A Parenteral (Water-miscible retinyl palmitate) NDC 64980-721